In the past week, RGC stock has gone up by 497.57%, with a monthly gain of 1132.36% and a quarterly surge of 9161.86%. The volatility ratio for the week is 70.50%, and the volatility levels for the last 30 days are 36.32% for Regencell Bioscience Holdings Ltd The simple moving average for the past 20 days is 363.20% for RGC’s stock, with a 2199.64% simple moving average for the past 200 days.
Is It Worth Investing in Regencell Bioscience Holdings Ltd (NASDAQ: RGC) Right Now?
The stock has a 36-month beta value of -4.15. Opinions on the stock are mixed, with 7 analysts rating it as a “buy,” 2 as “overweight,” 5 as “hold,” and 1 as “sell.”
The public float for RGC is 0.80M, and at present, short sellers hold a 2.37% of that float. On May 12, 2025, the average trading volume of RGC was 699.71K shares.
RGC) stock’s latest price update
The stock price of Regencell Bioscience Holdings Ltd (NASDAQ: RGC) has jumped by 72.65 compared to previous close of 212.00. Despite this, the company has seen a gain of 497.57% in its stock price over the last five trading days. globenewswire.com reported 2025-05-06 that ROANOKE, Va., May 06, 2025 (GLOBE NEWSWIRE) — RGC Resources, Inc. (Nasdaq: RGCO) announced consolidated Company earnings of $7,676,208, or $0.74 per share, for the second quarter ended March 31, 2025, compared to $6,443,390, or $0.63 per share, for the second quarter ended March 31, 2024. The primary drivers of the increased earnings were higher base rates that went into effect July 1, 2024 and increased volumes, offset by lower earnings from unconsolidated affiliate and higher interest expense.
RGC Trading at 706.84% from the 50-Day Moving Average
After a stumble in the market that brought RGC to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 36.20% of gains for the given period.
Volatility was left at 36.32%, however, over the last 30 days, the volatility rate increased by 70.50%, as shares surge +1,196.07% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7,431.07% upper at present.
During the last 5 trading sessions, RGC rose by +497.57%, which changed the moving average for the period of 200-days by +2,346.59% in comparison to the 20-day moving average, which settled at $79.02. In addition, Regencell Bioscience Holdings Ltd saw 7309.11% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for RGC
The total capital return value is set at -0.29. Equity return is now at value -42.49, with -40.85 for asset returns.
Currently, EBITDA for the company is -3.62 million with net debt to EBITDA at 0.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 41.92.
Conclusion
To sum up, Regencell Bioscience Holdings Ltd (RGC) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
